aiGENE, Inc

First low cost, in office, test to determine if a cancer regimen is working. A novel, method measures cancer DNA in the blood. 3:1 $ leverage/matching grant.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Founded September 2020
  • Employees 2
  • Incorporation Type C-corp
  • Website aiGENE.us

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free